Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 24, No. 5-6, 2009
Issue release date: November 2009
Section title: Original Paper
Cell Physiol Biochem 2009;24:547–556

Gene Expression Patterns in Visceral and Subcutaneous Adipose Depots in Rats are Linked to Their Morphologic Features

Palou M. · Priego T. · Sánchez J. · Rodríguez A.M. · Palou A. · Picó C.
Molecular Biology, Nutrition and Biotechnology (Nutrigenomics), University of the Balearic Islands (UIB), and CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Palma de Mallorca
email Corresponding Author

Prof. Andreu Palou

Universidad de las Islas Baleares

Edificio Mateu Orfila

Cra. Valldemossa Km 7.5, Palma de Mallorca 07122 (Spain)

Tel. +34 971173170, Fax: +34 971173426, E-Mail andreu.palou@uib.es

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


The aim was to characterize the expression pattern of genes involved in lipid metabolism in internal (retroperitoneal, mesenteric) and subcutaneous (inguinal) adipose tissue depots in rats and their relation with site-specific morphological- and metabolic-features. Gene expression by RT-qPCR, western blot and morphometric analyses were performed. Lipogenesis-related genes (PPARγ2, SREBP1c, ACC1, GPAT, LPL, CD36, GLUT4) showed higher mRNA levels in the retroperitoneal depot versus the mesenteric and the inguinal depots; the expression of PPARgamma;2, ACC1, CD36, and GLUT4 in the mesenteric depot was also higher than in the inguinal depot. HKII was similarly expressed in the retroperitoneal and mesenteric depots and higher than in the inguinal one. The expression of lipolysis-related genes (HSL, ATGL) was higher in the retroperitoneal than in the mesenteric and inguinal depots, while the expression of fatty-acid oxidation-related genes (PPARα, CPT1) was lower in the retroperitoneal depot compared with the mesenteric and the inguinal depots. Thus, a higher expression of lipogenesis- and lipolysis-related genes and lower expression of fatty-acid oxidation-related genes in internal depots (particularly in the retroperitoneal, which also presents the largest adipocyte size) can explain its higher triacylglyceride turnover rates and hence account for the differential behavior of fat depots in physiological situations and its involvement in obesity-linked metabolic disorders.

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Accepted: July 14, 2009
Published online: November 04, 2009
Issue release date: November 2009

Number of Print Pages: 10
Number of Figures: 0
Number of Tables: 0

ISSN: 1015-8987 (Print)
eISSN: 1421-9778 (Online)

For additional information: http://www.karger.com/CPB

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.